Elexacaftor/Tezacaftor/Ivacator effect on bone density and body composition - a Real-World retrospective analysis

被引：0
|
作者：
Trost, Susanne [1 ]
Harindhanavudhi, Tasma [1 ]
Wang, Qi [2 ]
Avula, Sreekant [3 ]
Moheet, Amir [3 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Clin & Translat Sci Inst, Los Angeles, CA USA
[3] Univ Minnesota, Div Diabet Endocrinol & Metab Internal Med, Minneapolis, MN USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SUN-022
引用
收藏
页码：235 / 235
页数：1
相关论文
共 50 条
  • [1] QUALITY OF LIFE IMPROVEMENT AFTER INITIATION OF ELEXACAFTOR-TEZACAFTOR-IVACAFTOR: A REAL-WORLD STUDY
    Powers, C.
    Yeley, J.
    Teibel, H.
    Crowley, E.
    Brown, C. D.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S275 - S275
  • [2] Real-world effectiveness of elexacaftor/tezacaftor/ivacaftor on the burden of illness in adolescents and adults with cystic fibrosis
    Keens, Thomas
    Hoffman, Veena
    Topuria, Ia
    Elder, Ken
    Cerf, Shannon
    Mulder, Kyra
    Roberts, Jon
    Lysinger, Jerimiah
    Del Carmen Reyes, Maria
    Berdella, Maria
    Cairns, Anne Marie
    Jain, Manu
    Ganapathy, Vaidyanathan
    Lou, Yiyue
    Morcos, Bassem
    Wu, Chuntao
    Sass, Laura
    HELIYON, 2024, 10 (07)
  • [3] Real-World Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Triple Combination Therapy in Pediatric Patients with Cystic Fibrosis
    Nazzari, E.
    Russo, M.
    Faelli, N.
    Rosazza, C.
    Bricchi, S.
    Rizza, C.
    Alicandro, G.
    Dacco, V
    PEDIATRIC PULMONOLOGY, 2023, 58 : S115 - S115
  • [4] Real-world safety profile of elexacaftor/tezacaftor/ivacaftor: a disproportionality analysis using the US FDA adverse event reporting system
    Zhu, Chengyu
    Cui, Zhiwei
    Liu, Tingting
    Lou, Siyu
    Zhou, Linmei
    Chen, Junyou
    Zhao, Ruizhen
    Wang, Li
    Ou, Yingyong
    Zou, Fan
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [5] Impact of Elexacaftor/Tezacaftor/Ivacaftor on Cystic Fibrosis Liver Tests in a Real-World Cohort with and Without Baseline CFLD
    Bowen, M.
    Sample, E.
    Collins, A.
    Singhal, A.
    Brown, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [6] Real-world impact of Elexacaftor-Tezacaftor-Ivacaftor treatment in young people with Cystic Fibrosis: A longitudinal study
    Connett, Gj
    Maguire, S.
    Larcombe, Tc
    Scanlan, N.
    Shinde, Ss
    Muthukumarana, T.
    Bevan, A.
    Keogh, Rh
    Legg, Jp
    RESPIRATORY MEDICINE, 2025, 236
  • [7] Real-World Outcomes: Lung Clearance Index Improvements in Danish Children with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/ Ivacaftor
    Henriksen, Esben Herborg
    Sandvik, Rikke Mulvad
    Faurholt-Jepsen, Daniel
    Olsen, Mette F.
    Pressler, Tacjana
    Bryrup, Thomas
    Buchvald, Frederik F.
    Mathiesen, Inger H. M.
    Qvist, Tavs
    Olesen, Hanne V.
    Rubak, Hanne L. M.
    Skov, Hanne L. M.
    Jensen, Camilla Bjorn
    Nielsen, Kim Gjerum
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 99 - 99
  • [8] Bone Mineral Density as a Predictor of Cardiovascular Disease in Women: A Real-World Retrospective Study
    Renjithlal, Sarath Lal Mannumbeth
    Magdi, Mohamed
    Mostafa, Mostafa Reda
    Renjith, Keerthi
    Pillai, Parvathi
    Syed, Musaib
    Mohamed, Sarah
    Zahid, Viqarunnisa
    Ritter, Nathan
    Al Ali, Omar
    Balmer-Swain, Mallory
    Makaryus, Amjad
    Pillai, Nisha
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2022, 12 (4-5) : 125 - 133
  • [9] Weight a minute: Exploring the effect on weight and body composition after the initiation of elexacaftor/tezacaftor/ivacaftor in adults with CF
    Proud, David
    Duckers, Jamie
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (05) : 847 - 850
  • [10] Sustained Improvement of Cystic Fibrosis Lung Disease following Initiation of Elexacaftor/Tezacaftor/Ivacaftor Therapy: Lessons from Real-World Studies
    Steinke, Eva
    Stahl, Mirjam
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (09) : 911 - 913
12345